OMCL ファイナンス： Omnicell Inc AI分析

ホーム

株式

OMCL

OMCL 財務

Omnicell Inc

$36.5

0.88%

$0.32

終値： Feb 13, 16:00:00 GMT-5

$36.5

アフターマーケット：Feb 13, 20:00:00 GMT-5

概要予測収入配当財務状況

360

レポート

B+

最終スコア

主要データ

前終値

$36.18

始値

$36.2

当日レンジ

$36.18 - $37.03

52週レンジ

$22.66 - $55

取引高

490.3K

平均取引高

590.4K

1株当たり利益(TTM)

0.42

配当利回り

時価総額

$1.6B

OMCLとは何ですか？

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,600 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

特徴

リソース

市場

収入

貸借対照表

現金の流れ

年次

四半期

OMCL 収入

金額は百万米ドル単位。会計年度は2月から1月まで。

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
収入	1,184	1,184	1,112	1,147	1,295	1,132
収益成長率（YoY）	6%	6%	-3%	-11%	14%	27%
収益のコスト	681	681	636	647	698	577
売上総利益	503	503	475	499	597	555
販売、一般および管理	409	409	380	425	475	387
研究開発	88	88	89	93	101	75
運営費用	498	498	470	519	576	463
その他の非営業収入（費用）	--	--	--	--	--	--
税引前利益	11	11	25	-20	-2	66
所得税費	9	9	13	0	-8	-11
純利益	2	2	12	-20	5	77
純利益成長率	-83%	-83%	-160%	-500%	-94%	141%
流通済み株式数（希薄化後）	44.95	46.36	46.25	45.21	45.9	47.9
株式変動（前年比）	-5%	0%	2%	-2%	-4%	10%
EPS（希薄化）	0.04	0.04	0.27	-0.45	0.12	1.62
EPS成長率	-83%	-84%	-160%	-476%	-93%	119%
フリーキャッシュフロー	66	66	134	126	17	173
1株当たりフリーキャッシュフロー	--	--	--	--	--	--
粗利益	42.48%	42.48%	42.71%	43.5%	46.1%	49.02%
営業利益率	0.42%	0.42%	0.44%	-1.65%	1.54%	8.03%
利益率	0.16%	0.16%	1.07%	-1.74%	0.38%	6.8%
フリーキャッシュフロー利益率	5.57%	5.57%	12.05%	10.98%	1.31%	15.28%
EBITDA	83	83	87	68	106	164
EBITDAマージン	7.01%	7.01%	7.82%	5.92%	8.18%	14.48%
D&A による EBITDA	78	78	82	87	86	73
営業利益	5	5	5	-19	20	91
営業利益率	0.42%	0.42%	0.44%	-1.65%	1.54%	8.03%
実効税率	81.81%	81.81%	52%	0%	400%	-16.66%

Omnicell Inc (OMCL)価格

OMCL 株価推移チャート